docgo inc - DCGO

DCGO

Close Chg Chg %
0.88 0.01 0.82%

Open Market

0.89

+0.01 (0.82%)

Volume: 214.34K

Last Updated:

Dec 31, 2025, 10:34 AM EDT

Company Overview: docgo inc - DCGO

DCGO Key Data

Open

$0.87

Day Range

0.87 - 0.89

52 Week Range

0.86 - 5.67

Market Cap

$87.05M

Shares Outstanding

97.81M

Public Float

80.80M

Beta

0.93

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.52

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

714.65K

 

DCGO Performance

1 Week
 
-5.01%
 
1 Month
 
-14.53%
 
3 Months
 
-30.69%
 
1 Year
 
-79.24%
 
5 Years
 
N/A
 

DCGO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About docgo inc - DCGO

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

DCGO At a Glance

DocGo, Inc.
685 Third Avenue
New York, New York 10017
Phone 1-844-443-6246 Revenue 616.56M
Industry Medical/Nursing Services Net Income 19.99M
Sector Health Services Employees 4,400
Fiscal Year-end 12 / 2025
View SEC Filings

DCGO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 23.207
Price to Sales Ratio 0.752
Price to Book Ratio 1.346
Price to Cash Flow Ratio 6.60
Enterprise Value to EBITDA 9.561
Enterprise Value to Sales 0.691
Total Debt to Enterprise Value 0.134

DCGO Efficiency

Revenue/Employee 140,126.166
Income Per Employee 4,543.669
Receivables Turnover 2.923
Total Asset Turnover 1.303

DCGO Liquidity

Current Ratio 2.50
Quick Ratio 2.50
Cash Ratio 0.733

DCGO Profitability

Gross Margin 32.064
Operating Margin 4.653
Pretax Margin 4.501
Net Margin 3.243
Return on Assets 4.226
Return on Equity 6.431
Return on Total Capital 5.287
Return on Invested Capital 6.10

DCGO Capital Structure

Total Debt to Total Equity 17.82
Total Debt to Total Capital 15.125
Total Debt to Total Assets 12.551
Long-Term Debt to Equity 5.807
Long-Term Debt to Total Capital 4.929
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Docgo Inc - DCGO

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
318.72M 440.52M 624.29M 616.56M
Sales Growth
- +38.21% +41.72% -1.24%
Cost of Goods Sold (COGS) incl D&A
216.48M 296.36M 445.34M 418.87M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
7.51M 10.57M 16.43M 15.88M
Depreciation
5.67M 7.35M 11.18M 10.22M
Amortization of Intangibles
1.85M 3.21M 5.25M 5.66M
COGS Growth
- +36.90% +50.27% -5.94%
Gross Income
102.24M 144.16M 178.95M 197.69M
Gross Income Growth
- +41.00% +24.14% +10.47%
Gross Profit Margin
+32.08% +32.72% +28.66% +32.06%
2021 2022 2023 2024 5-year trend
SG&A Expense
86.88M 120.86M 163.90M 169.00M
Research & Development
3.32M 5.38M 10.86M 11.59M
Other SG&A
83.56M 115.47M 153.04M 157.41M
SGA Growth
+51,359.55% +39.11% +35.61% +3.12%
Other Operating Expense
- - - -
-
Unusual Expense
(5.34M) 1.87M (1.44M) (1.05M)
EBIT after Unusual Expense
20.70M 21.43M 16.49M 29.74M
Non Operating Income/Expense
(141.25K) 1.36M (198.35K) 173.26K
Non-Operating Interest Income
- 762.68K 1.68M 236.95K
Equity in Earnings of Affiliates
(66.82K) 8.92K (343.34K) (316.04K)
Interest Expense
- - 763.03K 2.17M
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - 763.03K 2.17M
-
Interest Capitalized
- - - -
-
Pretax Income
19.80M 22.78M 16.29M 27.75M
Pretax Income Growth
+568.69% +15.09% -28.48% +70.31%
Pretax Margin
+6.21% +5.17% +2.61% +4.50%
Income Tax
615.70K (7.96M) 6.24M 14.39M
Income Tax - Current - Domestic
615.70K 2.00M 8.23M 10.92M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (10.33M) (1.61M) 3.47M
Income Tax - Deferred - Foreign
- - 375.30K (375.30K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
(66.82K) 8.92K (343.34K) (316.04K)
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
19.18M 30.74M 10.05M 13.36M
Minority Interest Expense
(4.56M) (3.84M) 3.19M (6.63M)
Net Income
23.74M 34.58M 6.86M 19.99M
Net Income Growth
+662.18% +45.66% -80.17% +191.50%
Net Margin Growth
+7.45% +7.85% +1.10% +3.24%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
23.74M 34.58M 6.86M 19.99M
Preferred Dividends
- - - -
-
Net Income Available to Common
23.74M 34.58M 6.86M 19.99M
EPS (Basic)
0.2957 0.3416 0.0663 0.1952
EPS (Basic) Growth
+200.65% +15.52% -80.59% +194.42%
Basic Shares Outstanding
80.29M 101.23M 103.51M 102.40M
EPS (Diluted)
0.2503 0.3358 0.0649 0.1827
EPS (Diluted) Growth
+185.19% +34.16% -80.67% +181.51%
Diluted Shares Outstanding
94.86M 102.98M 105.62M 109.42M
EBITDA
22.87M 33.86M 31.49M 44.57M
EBITDA Growth
+13,645.51% +48.07% -7.01% +41.56%
EBITDA Margin
+7.18% +7.69% +5.04% +7.23%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 3.075
Number of Ratings 7 Current Quarters Estimate -0.12
FY Report Date 03 / 2026 Current Year's Estimate -0.386
Last Quarter’s Earnings -0.14 Median PE on CY Estimate N/A
Year Ago Earnings -0.648 Next Fiscal Year Estimate -0.223
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 5 5 3
Mean Estimate -0.12 -0.09 -0.39 -0.22
High Estimates -0.07 -0.04 -0.29 -0.18
Low Estimate -0.17 -0.14 -0.53 -0.29
Coefficient of Variance -34.69 -40.23 -22.78 -26.24

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 4
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Docgo Inc - DCGO

Date Name Shares Transaction Value
Mar 12, 2025 Norman Rosenberg CFO and Treasurer 879,646 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Norman Rosenberg CFO and Treasurer 864,276 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.03 per share 2,618,756.28
Mar 12, 2025 Stephen Sugrue Chief Compliance Officer 360,731 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Stephen Sugrue Chief Compliance Officer 352,942 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.03 per share 1,069,414.26
Mar 12, 2025 Bienstock Lee Chief Executive Officer; Director 2,052,779 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Bienstock Lee Chief Executive Officer; Director 1,993,419 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.03 per share 6,040,059.57

Docgo Inc in the News